torsdag den 2 maj

Lifco: Sval byggsektor påverkar

Ludvig Löngårdh
Stockholmsbörsen
(), idag
-
-

Guard Therapeutics
Guard Therapeutics International: Next step for ROSgard (Redeye)

2019-11-13 11:24
Guard Therapeutics has received approval from the Swedish Medical Products Agency to try an even higher dose of ROSgard in their phase Ia program due to good safety profile. This will be the next step for ROSgard before entering the MAD study.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Guard Therapeutics Intl. - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -